Fertility Care Inequality by Region: A Comprehensive Review

Abstract

Fertility care is a critical component of reproductive health, yet access to and quality of such care is highly variable across different regions of the world. This review examines the multifactorial dimensions of fertility care inequality, analyzing epidemiological trends, underlying mechanisms, risk factors, clinical presentations, diagnostic approaches, management strategies, and emerging therapies. It integrates recent scientific evidence and established guidelines, offering practical implications for clinicians and healthcare policymakers.

Introduction

Infertility is recognized as a global health issue by the World Health Organization (WHO), affecting an estimated 8-12% of couples worldwide. Despite its prevalence and profound psychosocial impacts, fertility care remains unequally distributed, with significant disparities between and within regions. Factors such as socioeconomic status, healthcare infrastructure, cultural norms, and governmental policy contribute to these inequalities. Understanding the scope and determinants of fertility care inequality is essential for clinicians, researchers, and policymakers striving to advance reproductive health equity.

Epidemiology / Disease Burden

The global burden of infertility is substantial, with regional variations influenced by demographic, behavioral, and healthcare-related factors. High-income countries generally report lower prevalence rates of infertility due to better access to preventive and therapeutic interventions. Conversely, low- and middle-income regions experience higher disease burdens, often compounded by limited healthcare resources, high rates of untreated reproductive tract infections, and delayed diagnosis. According to WHO data, sub-Saharan Africa and South Asia exhibit the highest rates of infertility, with a significant proportion attributed to untreated infections and lack of specialized care. Regional disease burden also correlates with disparities in maternal age at first conception, contraceptive use, and prevalence of conditions such as polycystic ovary syndrome and endometriosis.

Pathophysiology

The pathophysiology underlying infertility is complex and multifactorial. In female infertility, common etiologies include ovulatory disorders, tubal factor infertility, endometriosis, and uterine pathology. Male infertility often arises from spermatogenic defects, endocrine dysfunction, or obstructive anomalies. Regional inequalities persist due to differential exposure to risk factors; for example, tubal damage secondary to sexually transmitted infections is more prevalent in regions with limited sexual and reproductive health services. Environmental toxins, undernutrition, and poorly managed chronic diseases further exacerbate infertility rates in resource-constrained settings.

Risk Factors

Risk factors for infertility are both universal and region-specific. Globally recognized factors include advanced maternal age, obesity, smoking, environmental exposures, and infections. However, the distribution of these risks is unequally weighted by region. In sub-Saharan Africa, untreated genital tract infections and postpartum complications are prominent contributors. In contrast, lifestyle-related factors such as delayed childbearing, obesity, and stress-related ovulatory dysfunction are more common in high-income areas. Socioeconomic deprivation and limited education further amplify risk in marginalized populations, while cultural barriers may restrict healthcare-seeking behavior, perpetuating cycles of undiagnosed and untreated infertility.

Clinical Features

Clinical presentation of infertility is often subtle and non-specific, typically defined by the inability to conceive after 12 months of regular unprotected intercourse. Ancillary symptoms may include menstrual irregularities, pelvic pain, or signs of endocrine dysfunction such as hirsutism or galactorrhea. In male patients, features such as erectile dysfunction or reduced libido may provide diagnostic clues. Regional disparities in clinical features reflect underlying etiological patterns; for example, chronic pelvic inflammatory disease and tubal occlusion are more frequently diagnosed in low-resource settings, while ovulatory disorders predominate in affluent regions.

Diagnosis

Diagnosis of infertility requires a comprehensive, multidisciplinary approach involving detailed history-taking, clinical examination, and targeted investigations. Standard diagnostic protocols include assessment of ovulatory function, tubal patency (via hysterosalpingography or laparoscopy), and semen analysis. However, access to advanced diagnostic modalities is highly variable across regions. In many low- and middle-income countries, limited laboratory infrastructure and high costs restrict the availability of key tests, leading to under-diagnosis or misdiagnosis. Efforts to implement simplified, cost-effective diagnostic algorithms have shown promise but are not yet universally adopted.

Treatment & Management

Treatment strategies for infertility encompass medical, surgical, and assisted reproductive technologies (ART). Ovulation induction, infection management, and surgical correction of anatomical defects remain first-line options in resource-limited settings. In contrast, high-resource regions offer a wide array of ART, including in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI). Access to ART is profoundly influenced by socioeconomic status, health insurance coverage, and regional policy frameworks. In some countries, ART is subsidized or publicly funded, while in others, prohibitive costs and restrictive legislation limit patient access. Comprehensive management also incorporates psychological support, emphasizing the profound emotional toll of infertility.

Recent Advances / Emerging Therapies

Recent advances in reproductive medicine are gradually closing the gap in fertility care, though regional disparities persist. Innovations such as low-cost IVF protocols, point-of-care diagnostic kits, and telemedicine consultations have improved access in underserved areas. Additionally, research into stem cell therapy, ovarian tissue cryopreservation, and genetic screening holds promise for expanding treatment options. Collaborative international programs, such as the WHO\'s Global Infertility Guidelines and initiatives by the International Federation of Fertility Societies, are fostering knowledge transfer and capacity-building in low-resource settings. However, equitable implementation of these advances remains a pressing challenge.

Guideline Recommendations

Global and regional guidelines emphasize the importance of integrated, patient-centered fertility care. WHO and European Society of Human Reproduction and Embryology (ESHRE) guidelines advocate for early evaluation, standardized diagnostic protocols, and stepwise management tailored to individual patient needs and regional resources. Recommendations also underscore the necessity of public health interventions to prevent infertility, including sexual health education, vaccination against preventable infections (e.g., HPV), and prompt treatment of reproductive tract diseases. Policymakers are urged to address barriers to ART access and to implement equitable funding mechanisms where feasible.

Conclusion

Fertility care inequality by region remains a significant global health concern, underpinned by complex socioeconomic, cultural, and healthcare system factors. Bridging these disparities requires a concerted effort from clinicians, researchers, and policymakers to ensure equitable access to effective diagnostic and therapeutic modalities. Continued innovation, policy reform, and international collaboration are essential to advance reproductive health equity and to realize the universal right to fertility care.